Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis

Phase 3 Completed 59 enrolled AbbVie

NaSingle-groupOpen-labelTreatment

This study assesses the long-term safety and efficacy of adalimumab in pediatric subjects with ulcerative colitis.

Evaluation	Drug	Modality	Dose	Route
Subject	Adalimumab	Monoclonal antibody	—	Subcutaneous